These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37955056)

  • 21. Quality of life, disability, and clinical variables in amyotrophic lateral sclerosis.
    Alencar MA; Silva IMMD; Hilário SM; Rangel MFA; Abdo JS; Araújo CM; Souza LC
    Arq Neuropsiquiatr; 2022 Mar; 80(3):255-261. PubMed ID: 34932653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.
    Prell T; Gaur N; Stubendorff B; Rödiger A; Witte OW; Grosskreutz J
    J Neurol Sci; 2019 Feb; 397():92-95. PubMed ID: 30597420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19.
    Brooks BR; Pioro EP; Katz J; Takahashi F; Takei K; Zhang J; Apple S
    Muscle Nerve; 2022 Feb; 65(2):180-186. PubMed ID: 34816454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
    Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
    No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical Activity in People With Motor Neuron Disease: Validity of the Physical Activity Scale for the Elderly as a Measuring Tool.
    Sia T; Connors KA; Morgan P
    Arch Phys Med Rehabil; 2023 Jan; 104(1):102-107. PubMed ID: 36179894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolonged interruption of rehabilitation routines in amyotrophic lateral sclerosis patients.
    Gonçalves F; Magalhães B
    Palliat Support Care; 2022 Jun; 20(3):369-374. PubMed ID: 33942709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of White Matter Tracts Fractional Anisotropy Using Tract-Based Spatial Statistics and Its correlation with Amyotrophic Lateral Sclerosis Functional Rating Scale Score in Patients with Motor Neuron Disease.
    Mohan AB; Adithan S; Narayan S; Krishnan N; Mathews D
    Indian J Radiol Imaging; 2021 Apr; 31(2):297-303. PubMed ID: 34556911
    [No Abstract]   [Full Text] [Related]  

  • 28. Pain-Related Coping Behavior in ALS: The Interplay between Maladaptive Coping, the Patient's Affective State and Pain.
    Schlichte I; Petri S; Dengler R; Meyer T; Haghikia A; Vielhaber S; Vogt S
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.
    Kwan JY; Meoded A; Danielian LE; Wu T; Floeter MK
    Neuroimage Clin; 2012; 2():151-60. PubMed ID: 24179768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonmotor Symptoms in Amyotrophic Lateral Sclerosis and Their Correlation With Disease Progression.
    Jaafar N; Malek E; Ismail H; Salameh J
    J Clin Neuromuscul Dis; 2021 Sep; 23(1):1-6. PubMed ID: 34431795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis.
    Hirayama T; Shibukawa M; Yanagihashi M; Warita H; Atsuta N; Yamanaka K; Kano O
    Acta Neurol Belg; 2023 Oct; 123(5):1797-1804. PubMed ID: 35987973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends of quality of life changes in amyotrophic lateral sclerosis patients.
    Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S
    J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R.
    Bakker LA; Schröder CD; Tan HHG; Vugts SMAG; van Eijk RPA; van Es MA; Visser-Meily JMA; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):75-81. PubMed ID: 31558653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.
    Diana A; Pillai R; Bongioanni P; O'Keeffe AG; Miller RG; Moore DH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006049. PubMed ID: 28067943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
    Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
    Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis - a longitudinal study.
    Wigand B; Schlichte I; Schreiber S; Heitmann J; Meyer T; Dengler R; Petri S; Haghikia A; Vielhaber S; Vogt S
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):284-291. PubMed ID: 34392762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale.
    Maier A; Boentert M; Reilich P; Witzel S; Petri S; Großkreutz J; Metelmann M; Lingor P; Cordts I; Dorst J; Zeller D; Günther R; Hagenacker T; Grehl T; Spittel S; Schuster J; Ludolph A; Meyer T;
    Neurol Res Pract; 2022 Dec; 4(1):60. PubMed ID: 36522775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2012 Dec; 12():CD005225. PubMed ID: 23235621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.
    Helleman J; Kruitwagen-van Reenen ET; Bakers J; Kruithof WJ; van Groenestijn AC; Jaspers Focks RJH; de Grund A; van den Berg LH; Visser-Meily JMA; Beelen A
    J Neurol; 2020 Nov; 267(11):3310-3318. PubMed ID: 32577867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
    Dal Bello-Haas V; Florence JM
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD005229. PubMed ID: 23728653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.